Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report

Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020.

Worldwide sales edged up 5% year-over-year to $12.5 billion but failed to match the expectations.

Net loss for the quarter was $2.09 billion or $0.83 per share compared to a profit of $2.35 billion or $0.92 per share last year.

The adjusted EPS increased by 17% to $1.32 per share.

  • Merck (MRK) Q2 2020 Earnngs Infograph
  • Merck & Co. announces financial results for first quarter 2020

Most Popular

Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note

UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next week. The company, a market leader in the nation's colossal

Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities

Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over the past few years, the toymaker has been focused on

AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%

AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding special items, was $0.04 per

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close